STOCK TITAN

Driehaus takes 9.79% passive position in Palatin Technologies (PTN) shares

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Driehaus Capital Management LLC, a Delaware investment adviser, reported beneficial ownership of 166,713 shares of Palatin Technologies, Inc. common stock, representing 9.79% of the class as of 12/31/2025. Driehaus has shared power to vote and dispose of all these shares, with no sole voting or dispositive power.

The shares are held in fully discretionary accounts for investment advisory clients, including Driehaus Life Sciences Master Fund, L.P., which retain the right to receive dividends and sale proceeds. Driehaus certifies that the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Palatin.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



DRIEHAUS CAPITAL MANAGEMENT LLC
Signature:Janet McWilliams
Name/Title:Janet McWilliams/General Counsel
Date:02/17/2026

FAQ

What ownership stake does Driehaus Capital Management report in Palatin Technologies (PTN)?

Driehaus Capital Management reports beneficial ownership of 166,713 shares of Palatin Technologies common stock, representing 9.79% of the outstanding class as of December 31, 2025. This makes Driehaus a significant institutional shareholder in the company.

Does Driehaus Capital Management control the Palatin Technologies (PTN) shares it reports?

Driehaus Capital Management reports shared voting and dispositive power over 166,713 Palatin shares and no sole power. The shares are held in discretionary client accounts, meaning Driehaus acts as investment adviser rather than direct owner.

Is Driehaus Capital Management’s Palatin (PTN) position intended to influence control of the company?

Driehaus states the Palatin shares were acquired and held in the ordinary course of business and not for changing or influencing control. The position is described as a passive investment under the Schedule 13G framework.

Who ultimately benefits from the Palatin (PTN) shares reported by Driehaus Capital Management?

The filing explains that the securities are held for investment advisory clients, including Driehaus Life Sciences Master Fund, L.P. Those clients have the right to receive dividends and sale proceeds from the Palatin shares reported.

Why did Driehaus Capital Management file a Schedule 13G for Palatin Technologies (PTN)?

A Schedule 13G is required when an investor holds more than 5% of a company’s shares on a passive basis. Driehaus crossed this threshold in Palatin, reporting 9.79% beneficial ownership while certifying the stake is not for control purposes.

What voting powers does Driehaus have over Palatin Technologies (PTN) stock?

Driehaus reports shared voting power over 166,713 shares and no sole voting power. It similarly has shared dispositive power over the same number of shares, reflecting its role managing client accounts that hold the stock.
Palatin Tech

NYSE:PTN

PTN Rankings

PTN Latest News

PTN Latest SEC Filings

PTN Stock Data

29.61M
1.68M
Pharmaceutical Preparation Manufacturing
Pharmaceutical Preparations
Link
US
CRANBURY